Oncimmune appoints new director

Oncimmune Holdings has appointed Annalisa Jenkins as a new non-executive director.

Jenkins was previously chief executive of Dimension Therapeutics, a gene therapy company focused on developing novel treatments for rare diseases.

At 9:52am: (LON:ONC) Oncimmune Holdings Plc share price was 0p at 127.5p